Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Type
Type
Guidance (16)
Guidance programme
(
3 selected
)
Guidance programme
Cancer service guidelines (0)
Clinical guidelines (26)
Diagnostics guidance (8)
Health technology evaluations (17)
HealthTech guidance (1)
Highly specialised technologies guidance (6)
Interventional procedures guidance (16)
Medical technologies guidance (10)
NICE guidelines (32)
Public health guidelines (1)
Technology appraisal guidance (335)
Apply filters
Showing 1 to 16 of 16
Sort by
Title
Date
Apply sorting
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Cancer service guidelines
Remove Guidance programme: Cancer service guidelines filter
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
Highly specialised technology
TBC
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (MA review of HST12) [ID6145]
Highly specialised technology
TBC
Digital technologies delivering CBT for insomnia and insomnia symptoms (provisional title)
Health technology evaluation
TBC
Digital technologies for managing mild to moderate symptoms of hip or knee osteoarthritis: early-value assessment
Health technology evaluation
16 January 2026
Digital technologies for multidisciplinary weight management
Health technology evaluation
TBC
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age [ID6484]
Highly specialised technology
5 June 2026
Ex-situ machine perfusion devices for deceased donor liver transplants
Health technology evaluation
20 August 2026
GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain
Medical technologies guidance
TBC
Non-invasive skin closure devices for surgical incisions (MT775)
Medical technologies guidance
TBC
Peezy Midstream for urine collection (MT446)
Medical technologies guidance
TBC
Pegzilarginase for treating arginase-1 deficiency [ID4029]
Highly specialised technology
18 December 2025
SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)
Medical technologies guidance
TBC
Surgical vessel sealing systems (MT798)
Medical technologies guidance
TBC
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]
Highly specialised technology
TBC
VTS-270 for treating Niemann-Pick type C1 [ID1267]
Highly specialised technology
TBC
Zio XT for detecting cardiac arrhythmias
Medical technologies guidance
TBC
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top